Ä¿¹Â´ÏƼ
- °øÁö»çÇ×
- ¹®ÀǴ亯
- ÁÖ¹®³»¿ª
- »ç¿ëÈıâ
 
¹¯°í ´äÇϱâ
Gal3Gher (zvG12r8@naver.com )   (¿¬¶ôó : zv1Gz17.com )      1¿ù 1ÀÏ 22½Ã 56ºÐ  Á¶È¸¼ö: 120
supporters, the eligibility ¼öÁ¤ »èÁ¦
The 2010s will also be ±¸Âî=±¸Âî¿©¼ºÀÇ·ù
remembered for the decade-long saga of Caster Semenya, a story that continues to divide opinion in sport like little else.

In 2019, the Court of Arbitration for Sport (Cas) ruled ¸íǰ·¹Çø®Ä«»çÀÌÆ®=¸íǰ·¹Çø®Ä«»çÀÌÆ®
in favour of a hugely controversial IAAF rule that forced the South African runner - and other athletes with differences in sexual development (DSD) - to take hormone-limiting drugs if she wanted to compete in the middle-distance events she had dominated for years. After a long legal battle, Semenya pulled out of the World Championships.

For Semenya's supporters, the eligibility regulation was an appalling breach of human rights and a ³ÃÁ¤¼ö±â·»Å»=¿õÁøÄÚ¿þÀÌ ³ÃÁ¤¼ö±â·»Å» Á¦ºù±â°â¿ë ½Ç¹ö / CPI-6500LÃÖ°í
discriminatory act of sexism and racism designed to target her. For others, it was a necessary and proportionate step to protect women's sport and fair competition.

But whatever one's perspective, there is no doubt that the debate has confronted sport with uncomfortable questions ¿äÁö¾ß¸¶¸ðÅä=¿äÁö¾ß¸¶¸ðÅä¿©¼ºÀÇ·ù
around gender identity and human biology, the suitability of sport's traditional male and female categories, È«Äá¸íǰ³²¼º°¡¹æ=È«Äá¸íǰ³²¼º°¡¹æ È«Äá¸íǰ¿©¼º°¡¹æ È«Äá¸íǰ³²¼ºÁö°©
the reliability of the medical science on which the IAAF's rule relies, perceptions of womanhood and sport's complex relationship with the law.
  ¸ñ·ÏÀ¸·Î